Updated: January 28, 2026
How to Help Your Patients Save Money on Naphazoline: A Provider's Guide to Savings Programs
Author
Peter Daggett

Summarize with AI
- Naphazoline Pricing Overview for 2026
- Key Savings Strategy 1: Recommend Store-Brand Generics
- Key Savings Strategy 2: Counsel on HSA/FSA Eligibility
- Key Savings Strategy 3: Write a Prescription When Beneficial
- When the Cost-Conscious Choice Is a Different Drug Entirely
- Patient Access Barriers Beyond Cost
- Using medfinder to Reduce Access Barriers for Patients
- Quick Reference: Provider Savings Counseling Checklist
A provider's guide to helping patients afford naphazoline and related eye care products in 2026, including HSA/FSA guidance, store brands, and when to redirect to alternatives.
Naphazoline is one of the most accessible and affordable medications in eye care — available OTC at $7–$20 per bottle without a prescription. However, patients still ask about cost optimization, especially when they're managing multiple eye care needs or using higher-cost alternatives. This guide gives providers the information needed to counsel patients effectively on naphazoline costs and savings strategies in 2026.
Naphazoline Pricing Overview for 2026
Standalone naphazoline was discontinued by its manufacturers. Naphazoline combination products remain available OTC. Key price points:
Clear Eyes Redness Relief (15mL): $7–$12 at major pharmacy chains
Naphcon-A / Visine-A / Opcon-A (15mL): $10–$18 (with pheniramine antihistamine)
Store-brand equivalents: $5–$10 — same active ingredients, lower cost
No prescription is required for any of the above. These products are not covered by standard health insurance as OTC items, though FSA/HSA cards are applicable (see below).
Key Savings Strategy 1: Recommend Store-Brand Generics
The most impactful cost-savings recommendation for naphazoline is directing patients to store-brand or private-label equivalents. These products contain identical active ingredients at the same concentrations as national brands, at 20–40% lower cost.
Advise patients to check the active ingredient panel rather than the brand name. Naphazoline HCl at the same concentration as the branded product is therapeutically equivalent. Examples:
CVS Health Redness Relief Eye Drops = equivalent to Clear Eyes Redness Relief
Walgreens Allergy & Redness Relief Eye Drops = equivalent to Naphcon-A
Key Savings Strategy 2: Counsel on HSA/FSA Eligibility
Since the passage of the CARES Act (2020), OTC medications are eligible for Health Savings Account (HSA) and Flexible Spending Account (FSA) purchases without a prescription. This is a meaningful benefit for patients with high-deductible health plans who purchase OTC eye care products regularly.
Counsel patients to pay for naphazoline products with their HSA or FSA card directly at the pharmacy. This allows them to use pre-tax dollars, effectively reducing the cost by their marginal tax rate (15–25% for most patients).
Key Savings Strategy 3: Write a Prescription When Beneficial
In some situations, writing a prescription for a specific naphazoline combination product may trigger insurance coverage:
Some state Medicaid programs cover OTC medications when prescribed; check your state's formulary
Some commercial plans cover OTC eye drops as a Tier 1 benefit when prescribed — especially for patients with documented ophthalmic conditions
Specify the combination product by brand name (e.g., "Naphcon-A (naphazoline 0.027%/pheniramine 0.315%) ophthalmic solution, 15mL, one bottle") to facilitate processing
When the Cost-Conscious Choice Is a Different Drug Entirely
For patients who are repeatedly purchasing naphazoline for allergy-related eye symptoms, switching to a once-daily antihistamine/mast cell stabilizer may be more cost-effective over a full allergy season:
Ketotifen (Alaway, Zaditor) OTC: $10–$20/bottle, used twice daily, treats allergic itching and redness without rebound risk
Olopatadine 0.2% (Pataday) OTC: $15–$30/bottle, used once daily, longer-acting, strong efficacy evidence for allergic conjunctivitis
A patient spending $15 every 2 weeks on naphazoline products for allergy symptoms might spend less long-term on a single $25 bottle of Pataday that lasts 2 months with once-daily use.
Patient Access Barriers Beyond Cost
Even with affordable pricing, some patients face access barriers — particularly patients without reliable transportation, those in pharmacy deserts, or patients managing multiple conditions who struggle to stay on top of OTC refills. When cost isn't the primary barrier but access is, referral to medfinder may be the most useful intervention.
Using medfinder to Reduce Access Barriers for Patients
For patients who have difficulty locating a specific naphazoline product at their regular pharmacy, medfinder for providers provides a simple referral pathway. Patients submit their medication name and location. medfinder calls pharmacies in the area to check stock and texts the patient which ones have it available. This is particularly helpful for:
Elderly patients who may have difficulty navigating pharmacy websites
Patients in areas with inconsistent pharmacy stocking of specific OTC formulations
Patients seeking a specific combination product (e.g., pheniramine-containing for allergies vs. glycerin-containing for dryness)
Quick Reference: Provider Savings Counseling Checklist
Recommend store-brand equivalents to cut cost by 20–40%
Advise use of HSA/FSA card for all OTC eye care purchases
Consider writing a prescription if insurance coverage is possible for the patient
For chronic allergy patients, assess whether once-daily olopatadine or ketotifen is more cost-effective than frequent naphazoline purchases
For access barriers, refer patients to medfinder to locate specific products at pharmacies near them
Frequently Asked Questions
Yes, writing a prescription for a specific naphazoline combination product (e.g., Naphcon-A) can enable insurance coverage in some cases, particularly on Medicaid plans or commercial plans that cover OTC medications when prescribed. Check the patient's specific formulary and specify the full product name and dosage when writing the prescription.
Yes. Since the CARES Act of 2020, all OTC medications including eye drops are HSA and FSA eligible without a prescription. Patients can pay with their FSA or HSA card directly at the pharmacy, effectively using pre-tax dollars to reduce the net cost.
Store-brand (private label) redness reliever eye drops from CVS, Walgreens, Rite Aid, Walmart, or Target typically cost $5–$10 for a 15mL bottle — making them the most affordable option. These contain the same active ingredient (naphazoline HCl) at the same concentration as national brands like Clear Eyes.
Consider switching when: (1) the patient has chronic allergic conjunctivitis and would benefit from antihistamine/mast cell stabilizer therapy (olopatadine, ketotifen, alcaftadine); (2) the patient has developed rebound hyperemia from overuse and needs a supervised taper; or (3) OTC options are insufficient for the severity of symptoms.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Naphazoline also looked for:
More about Naphazoline
35,948 have already found their meds with Medfinder.
Start your search today.





